PSMA-617 inhibits proliferation and potentiates the <sup>177</sup>Lu-PSMA-617-induced death of human prostate cancer cells.
Journal Information
Full Title: Naunyn Schmiedebergs Arch Pharmacol
Abbreviation: Naunyn Schmiedebergs Arch Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Ethical approval and consent to participateNot applicable in this study. Consent for publicationNot applicable in this study. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
Funding Disclosure
Evidence found in paper:
"Funding Open Access funding enabled and organized by Projekt DEAL. The study was exclusively funded by the Department of Nuclear Medicine, Molecular Imaging, Diagnostic and Therapy, University Hospital Schleswig–Holstein, Campus Kiel, Germany."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025